Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share

v3.21.2
Earnings Per Share
9 Months Ended
Jun. 30, 2021
Earnings Per Share [Abstract]  
Earnings Per Share
The dilutive effects of performance-based stock awards were included in the computation of diluted earnings per share at the level the related performance criteria were met through the respective balance sheet date.  Potential dilutive effects, representing approximately 400,000 shares at both June 30, 2021 and 2020, were excluded from the computation of diluted earnings per share as the related performance criteria were not yet met, although the Company expects to meet various levels of criteria in the future.
Three Months Ended
June 30,
Nine Months Ended
June 30,
  2021 2020 2021 2020
Net income (loss) attributable to Hillenbrand $ 40.4  $ 24.0  $ 194.9  $ (53.1)
Weighted-average shares outstanding (basic - in millions) (1)
75.5  75.1  75.4  72.8 
Effect of dilutive stock options and other unvested equity awards (in millions) (2)
0.7  —  0.5  — 
Weighted-average shares outstanding (diluted - in millions) 76.2  75.1  75.9  72.8 
Basic earnings (loss) per share $ 0.54  $ 0.32  $ 2.59  $ (0.73)
Diluted earnings (loss) per share $ 0.53  $ 0.32  $ 2.57  $ (0.73)
Shares with anti-dilutive effect excluded from the computation of diluted earnings per share (in millions) 0.1  2.8  0.8  2.9 
 
(1)The increase in weighted-average shares outstanding during the nine months ended June 30, 2021 was due to 11.9 million of additional shares issued on November 21, 2019 in connection with the acquisition of Milacron. See Note 4 for further information.
(2)As a result of the net loss attributable to Hillenbrand during the nine months ended June 30, 2020, the effect of stock options and other unvested equity awards would be antidilutive. In accordance with GAAP, they have been excluded from the diluted earnings per share calculation.